The Diagnosis and Treatment of Sjogren's Syndrome.
Stefanski AL, Tomiak C, Pleyer U, Dietrich T, Burmester GR, Dörner T.
Dtsch Arztebl Int. 2017 May 26;114(20):354-361. doi: 10.3238/arztebl.2017.0354.
PMID:28610655
Non-primary Sjogren's Syndrome: Secondary or associated?
Felten R, Meyer A, Gottenberg JE.
Joint Bone Spine. 2023 Mar;90(2):105502. doi: 10.1016/j.jbspin.2022.105502. Epub 2022 Dec 1.
PMID:36464213
Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.
Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH; European Study Group on Classification Criteria for Sjögren's Syndrome.
Ann Rheum Dis. 2002 Jun;61(6):554-8. doi: 10.1136/ard.61.6.554.
Yonsei Med J. 2003 Dec 30;44(6):947-54. doi: 10.3349/ymj.2003.44.6.947.
PMID:14703600
Efficacy and safety of remibrutinib, a selective potent oral BTK inhibitor, in Sjogren's syndrome: results from a randomised, double-blind, placebo-controlled phase 2 trial.
Dörner T, Kaul M, Szántó A, Tseng JC, Papas AS, Pylvaenaeinen I, Hanser M, Abdallah N, Grioni A, Santos Da Costa A, Ferrero E, Gergely P, Hillenbrand R, Avrameas A, Cenni B, Siegel RM.
Ann Rheum Dis. 2024 Feb 15;83(3):360-371. doi: 10.1136/ard-2023-224691.